相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Autophagy: an adaptive physiological countermeasure to cellular senescence and ischaemia/reperfusion-associated cardiac arrhythmias
Istvan Lekli et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
Donato Cappetta et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
Navid Koleini et al.
ONCOTARGET (2017)
Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
Mustafa Argun et al.
ANATOLIAN JOURNAL OF CARDIOLOGY (2016)
p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation
Wei Jing Liu et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2016)
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Dan L. Li et al.
CIRCULATION (2016)
Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats
A. Sheta et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2016)
AMPK: energy sensor and survival mechanism in the ischemic heart
Dake Qi et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Autophagy regulation by nutrient signaling
Ryan C. Russell et al.
CELL RESEARCH (2014)
Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study
Laura C. Kobashigawa et al.
PLOS ONE (2014)
The Cellular Autophagy Markers Beclin-1 and LC3B-II are Increased During Reperfusion in Fibrillated Mouse Hearts
Gregory Meyer et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Cardiac Toxicity of Anticancer Agents
Alessandro Colombo et al.
CURRENT CARDIOLOGY REPORTS (2013)
Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response
Najah Hadi et al.
BMC CARDIOVASCULAR DISORDERS (2012)
Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes
Tomonori Kawaguchi et al.
CARDIOVASCULAR RESEARCH (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
Steven E. Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Metformin Rescues the Myocardium from Doxorubicin-Induced Energy Starvation and Mitochondrial Damage in Rats
Abdelkader E. Ashour et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2012)
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Steven E. Lipshultz et al.
PEDIATRICS (2012)
Autophagy in the Cellular Energetic Balance
Rajat Singh et al.
CELL METABOLISM (2011)
Metformin protects against doxorubicin-induced cardiotoxicity: Involvement of the adiponectin cardiac system
Mari C. Asensio-Lopez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Cardiotoxicity After Childhood Cancer: Beginning With the End in Mind
Steven E. Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E. Lipshultz et al.
LANCET ONCOLOGY (2010)
Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure
Lihe Lu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Alterations in myocardial energy metabolism induced by the anti-cancer drug doxorubicin
Malgorzata Tokarska-Schlattner et al.
COMPTES RENDUS BIOLOGIES (2006)
Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus
F Abbasi et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
分享论文
